Trial intelligence / Profile preview

REDUCED-I: Oxytocin Discontinuation in Active Labor

NCT05037617Completed

Sponsor
University of Calgary
Start
Oct 2021
Primary completion
Feb 2024
Modality
Peptides
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin in induction of labor (2 arms), sponsored by University of Calgary. Primary endpoints: Rate of Cesarean section in labor, Occurrence of Uterine Hyperstimulation and 1 more. Started Oct 2021; status: completed.

02

Drugs

oxytocin
03

Conditions

induction of labor

Beyond the preview

Go deeper on NCT05037617.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05037617.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call